LRRK2-IN-24
LRRK2-IN-24 is an orally active, blood-brain barrier-penetrant and selective LRRK2 inhibitor (IC50 = 1.03 nM). LRRK2-IN-24 inhibits the activity of LRRK2 kinase against wild-type and G2019S mutant forms, and reduces the ratio of phosphorylated LRRK2 to total LRRK2 in mouse hippocampus and cortex. LRRK2-IN-24 can be used in research related to Parkinson's disease.
For research use only. We do not sell to patients.
- CAS No.: 3013598-24-5
- Formula: C21H24ClN7O2
- Molecular Weight:441.91
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
LRRK2-IN-24 is metabolically stable in human liver microsomes and mouse liver microsomes, with t1/2 of > 145 min and 84.0 min, respectively; it exhibits good Caco-2 permeability, with Papp A-B of 7.13 × 10-6 cm/s and an efflux ratio as low as 1.33[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3013598-24-5
-
Molecular Weight 441.91
-
Formula C21H24ClN7O2
-
SMILES
ClC1=CNC2=C1/C(N3)=N/CCCOC4=C(C=CC(N5CC6(CC(C6)OC)C5)=N4)/N=C3/N2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)